Companies formed
Since 1987, Oxford University Innovation has been responsible for creating spinout companies based on academic research generated within and owned by the University of Oxford, and in recent years has spun out 15-20 new companies every year.
Over £2.5bn in external investment has been raised by Oxford University Innovation spinouts since 2010, and ten of our current portfolio are currently listed in London and New York.
The creation of new spinout companies, most of which are listed below, also channels millions of pounds back into University research, benefits local economic development and has created many new jobs in the region.
Oxford Medical Diagnostics

Avacta
Breath analysis.
Incorporated in June 2004
Origin: Oxford University, Physical and Theoretical Chemistry
2003
Oxford Consultants for Social Inclusion


Oxford Consultants for Social Inclusion (OCSI) helps local government identify deprived neighbourhoods, target resources, evaluate programme effectiveness and strengthen regeneration bids.
Incorporated in August 2003
Origin: Oxford University, Department of Social Policy and Intervention
Riotech
ReOx
Summit plc


Summit Therapeutics is an international biopharmaceutical company focussed on the discovery and development of novel medicines to treat the fatal muscle wasting disease Duchenne muscular dystrophy and infections caused by the bacteria C. difficile.
Incorporated in February 2003
Origin: Oxford University, Department of Organic Chemistry
Summit Therapeutics


Chemical genomics.
Incorporated in February 2003
Origin: Oxford University
2002
BioAnaLab (acquired by Millipore Corp.)
BioAnalab offers a contract testing service to the biopharmaceutical industry for the rapidly growing area of therapeutic monoclonal antibodies, with a longer-term strategy to develop diagnostics to measure levels of monoclonal antibodies and their immune response. In July 2009, BioAnaLab was acquired by Millipore Corp.
Incorporated in November 2002
Origin: Oxford University, Department of Pathology
Oxford Risk


Oxford Risk is the market-leading provider of customer risk profilers. Their products reveal the level of risk customers are willing and able to take with their financial investments.
Incorporated in November 2002
Origin: Oxford University, Nuffield Department of Population Health
Oxford Immunotec (acquired by PerkinElmer)


Oxford Immunotec is a global, commercial-stage diagnostics company committed to improving patient care by providing advanced, innovative tests in the field of immunology. In 2021, Oxford Immunotec was acquired by PerkinElmer.
Incorporated in October 2002
Origin: Oxford University, Nuffield Department of Clinical Medicine
Oxitec (Intrexon)


Provide an environmentally-responsible method of controlling disease spreading pests.
Incorporated in August 2002
Origin: Oxford University, Zoology
Intrexon (Oxitec)


Controlling insects that spread disease.
Incorporated in August 2002
Origin: Oxford University, Zoology
Glycoform
Zyentia
Oxford Biomaterials


Biomimetic spinning of fibres.
Incorporated in March 2002
Origin: Oxford University
Minervation


Web-based healthcare knowledge.
Incorporated in February 2002
Origin: Oxford University, Psychiatry
Pharminox
2001
Oxford Drug Design (Inhibox)


Screensavers for drug candidates.
Incorporated in December 2001
Origin: Oxford University, Chemistry
NaturalMotion


Interactive character animation.
Incorporated in November 2001
Origin: Oxford University
Oxford Archdigital
